Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.

Conclusion: KL-6 is predictive biomarker useful in the clinical management of ILD patients, in particular in patients with severe fibrotic lung disorders.
PMID: 32613855 [PubMed - as supplied by publisher]

Source: Future Medicine: Biomarkers in Medicine - July 4, 2020 Category: Internal Medicine Tags: Biomark Med Source Type: research